New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
13:04 EDTTEVA, MYL, AZNCourt backs AstraZeneca, blocks generic Crestor, Bloomberg reports
A U.S. appeals court ruled in favor of AstraZeneca (AZN), saying its patent on Crestor is valid and enforceable and rejecting challenges made by generic-drug makers including Mylan (MYL) and Teva Pharmaceuticals (TEVA), reported Bloomberg. The ruling protects the valuable cholesterol medicine, which brought in $2.3B in revenue in the first nine months of this year in the U.S., the report noted. Reference Link
News For AZN;MYL;TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
April 10, 2015
11:30 EDTMYLStocks with call strike movement; MSFT MYL
Microsoft (MSFT) October 48 call option implied volatility increased 9% to 38, Mylan (MYL) July 85 call option implied volatility decreased 11% to 31 according to IVolatility.
10:36 EDTAZNAstraZeneca trades lower, levels to watch
Shares are down less than 1% to $69.54 at time of writing. At that price the stock is just above the 50-day moving average at $69.12. Since May of last year, price has oscillated around the 50-day, with the average acting as the approximate center line. Support below the 50-day is at $68.24.
09:25 EDTAZNFDA staff say analysis suggests Onglyza may increase risk of death
Subscribe for More Information
08:29 EDTMYLMylan price target raised to $80 from $66 at Argus
Argus hiked its price target on Mylan (MYL) after the company announced a non-binding proposal to acquire Perrigo Co. (PRGO) for $205 per share. The firm remains upbeat on the outlook for generic drugs in general, and says that generic over-the-counter pharmaceuticals, an area of focus for Perrigo, are rapidly taking share from brand-name OTC products. The firm keeps a Buy rating on Mylan
April 9, 2015
16:00 EDTMYLOptions Update; April 9, 2015
Subscribe for More Information
11:11 EDTMYLOptions with increasing implied volatility
Options with increasing implied volatility: TLM WETF GRPN TRIP GMCR MYL AOL WB WFM EA
10:13 EDTMYLHigh option volume stocks
Subscribe for More Information
09:51 EDTTEVA, MYLPerrigo did not expect Mylan takeover letter, CNBC's Faber reports
Perrigo (PRGO) did not expect the takeover letter it received from Mylan (MYL), CNBC's David Faber reports, citing sources. Perrigo will take its time in deciding what its next steps are, Faber added. Shares of Mylan are up 3% in early trading, which is being attributed, at least in part, to speculation the company could be a takeover target itself. Analysts this morning mentioned Teva (TEVA) as a potential acquirer of Mylan. Chatter this morning has Pfizer (PFE) also potentially interested in the EpiPen maker
09:25 EDTAZNPiper Jaffray pharmaceuticals analysts hold an analyst/industry conference call
Subscribe for More Information
09:06 EDTMYLBofA/Merrill pharmaceuticals analyst holds an analyst/industry conference call
Special Situations Analyst Paul Shea, along with Pharmaceuticals Analyst Sumant Kulkarni, discuss the Mylan/Perrigo deal on an Analyst/Industry conference call to be held on April 9 at 10 am.
08:30 EDTMYL, TEVAPotential bid for Mylan by Teva could provide profound synergies, says Cowen
Subscribe for More Information
08:14 EDTMYLMylan price target raised to $80 from $65 at Cowen
Subscribe for More Information
08:10 EDTMYL, TEVALeerink sees 70% chance of Mylan buying Perrigo with raised bid
Subscribe for More Information
06:20 EDTTEVA, MYLTeva bid for Mylan possible, but challenging, says Citigroup
Subscribe for More Information
06:15 EDTMYL, TEVACiti does not see much strategic sense in Mylan, Perrigo deal
Subscribe for More Information
06:02 EDTMYLPerrigo downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Perrigo (PRGO) to Market Perform after the stock rallied 18% yesterday on Mylan's (MYL) proposal to buy the company for $205 per share.
05:49 EDTTEVA, MYLStocks with implied volatility movement; MYL TEVA
Subscribe for More Information
April 8, 2015
16:22 EDTTEVA, MYLOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTMYLActionable Options for Wednesday, April, 8
Subscribe for More Information
15:27 EDTMYLMylan hasn't made compelling case for Perrigo adding value, says BMO Capital
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use